Heptru 400 Tablet is a pharmaceutical formulation designed to support hepatic function and promote liver health. This medication is indicated for patients experiencing various liver disorders, including hepatic insufficiency, chronic hepatitis, and fatty liver disease. Heptru 400 Tablet acts by enhancing liver cell regeneration, improving bile secretion, and reducing oxidative stress within hepatic tissues. The active components facilitate detoxification processes, thereby aiding in the removal of metabolic waste and toxins from the liver. It is commonly prescribed as an adjunct therapy in managing liver cirrhosis and other chronic liver conditions to improve overall liver function and patient quality of life. The tablet is administered orally, with dosage tailored according to the severity of the condition and patient response. Heptru 400 is generally well tolerated, with minimal adverse effects reported; however, monitoring for potential hypersensitivity reactions or gastrointestinal disturbances is advised. It is contraindicated in individuals with known hypersensitivity to any of its constituents and should be used cautiously in patients with severe renal impairment. Regular liver function tests are recommended during the course of treatment to assess therapeutic efficacy and detect any potential hepatotoxicity. Consultation with a healthcare professional is essential before initiating therapy with Heptru 400 Tablet.